

Keeping up with your Somatuline Depot (lanreotide) Injection therapy exactly as prescribed is essential to keeping acromegaly under control. Your endocrinologist will determine your treatment schedule based on your response to therapy.
Keeping to your prescribed injection schedule is essential to optimizing your treatment
*"Controlled" is defined as GH ≤ 2.5 µg/mL, normalized IGF-1, and clinical symptoms controlled.
If you are controlled on Somatuline Depot 60 mg or 90 mg you may be considered for an extended dosing interval of Somatuline Depot 120 mg every 6 or 8 weeks. GH and IGF-1 levels should be obtained 6 weeks after this change in dosing regimen to evaluate persistence of patient response.
Individual response to any acromegaly therapy will vary from patient to patient. Ask your endocrinologist if Somatuline® Depot therapy is right for you.
Your doctor is your primary source of information about treatment. For more information, please talk to your doctor and see the full Patient Information. Before each treatment, please read the Patient Information that comes with each package of Somatuline Depot (lanreotide) Injection, as there may be new information.
Somatuline Depot is a prescription medicine used for the long-term treatment of people with acromegaly when:
It is not known if Somatuline Depot is safe and effective in children.
Before taking Somatuline Depot, you should talk to your doctor about all of your medical conditions and medicines you are taking, including if you have:
Somatuline Depot may cause serious side effects, including:
The most common side effects of Somatuline Depot include: diarrhea, stomach area (abdominal) pain, nausea, and pain, itching, or lump at the injection site.
Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of Somatuline Depot. For more information ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.